Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
September 19, 2024 17:25 ET | Cayson Acquisition Corp.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s...
singular logo.png
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
September 19, 2024 17:24 ET | Singular Genomics Systems, Inc.
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
logo (1).jpg
VirTra Sets 2024 Annual Meeting of Shareholders for Monday, October 21, 2024
September 19, 2024 17:18 ET | VirTra, Inc.
CHANDLER, Ariz., Sept. 19, 2024 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators, firearms training...
DB LOGO+Text_2-Color.png
Diamondback Energy Announces Launch of Secondary Common Stock Offering
September 19, 2024 16:55 ET | Diamondback Energy, Inc.
MIDLAND, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today the launch of an underwritten public offering of 11,270,000 shares of its...
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
September 19, 2024 16:30 ET | Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
biodexa-logo-square (1).png
ADR Ratio Change
September 19, 2024 16:30 ET | Biodexa Pharmaceuticals PLC
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...
Dime Community Bancshares 400x400.jpg
Dime Enhances Middle Market Lending Presence on Long Island
September 19, 2024 16:30 ET | Dime Community Bancshares, Inc.
HAUPPAUGE, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced that it...
Territorial Bancorp Inc. Logo
Territorial Bancorp Reaffirms Its Board’s Commitment to Proposed Merger with Hope Bancorp
September 19, 2024 16:30 ET | Territorial Bancorp Inc.
HONOLULU, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Territorial Bancorp Inc. (“Territorial”) today reaffirmed the commitment of its Board of Directors to the proposed merger with Hope Bancorp, Inc....
MillicomTigo-azul-transparente.png
Millicom (Tigo) Executive Chair Mauricio Ramos steps down as Chair of the Board Maxime Lombardini to assume as Non-Executive Interim Chair
September 19, 2024 16:15 ET | Millicom International Cellular S.A.
Millicom (Tigo) Executive Chair Mauricio Ramos steps down as Chair of the Board Maxime Lombardini to assume as Non-Executive Interim Chair Luxembourg, September 19, 2024...
Zenas Logo.jpg
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
September 19, 2024 16:15 ET | Zenas BioPharma
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...